Filter trials by:

Year

Indication

Phase

Type

Year: 2020

Upadacitinib treatment patterns, achievement of treatment targets and maintenance of response in moderate to severe Rheumatoid Arthritis patients in real-world practice (UPHOLD).

Year: 2020
Type: Musculoskeletal
Phase: Post-Market
Indication: Rheumatoid Arthritis

A Phase 3, Randomized, Double blind, Placebo controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response or are Intolerant to Biologic DMARD Therapy.

Year: 2020
Type: Musculoskeletal
Phase: III
Indication: Psoriatic Arthritis

A Phase 3, Randomized, Double-blind, Placebo and Adalimumab-controlled Study to Evaluate the Efficacy and Safety of Filgotinib in Subjects with Active Psoriatic Arthritis Who Are Naïve to Biologic DMARD Therapy.

Year: 2020
Type: Musculoskeletal
Phase: III
Indication: Psoriatic Arthritis

A Randomized, Controlled, Multi-Center, Non-inferiority Trial to Evaluate the Safety and Efficacy of Ultra-Low Frequency Spinal Cord Stimulation Compared to Traditional Spinal Cord Stimulation in Subjects with Chronic Back Pain with / without Leg Pain.

Year: 2020
Type: Device
Phase: Pre-Market
Indication: Back and/or Leg Pain

A Phase 3, Randomized, Double-blind, Placebo- and Active controlled Study to Evaluate the Efficacy and Safety of TLC599 in Patients with Osteoarthritis of the Knee.

Year: 2020
Type: Musculoskeletal
Phase: III
Indication: Knee Osteoarthritis